Effectiveness and safety of protease inhibitor-based regimens in HIV-infected Thai children failing first-line treatment

Effectiveness and safety of protease inhibitor-based regimens in HIV-infected Thai children failing first-line treatment

Objectives: Virological failure on first-line nonnucleoside reverse transcriptase inhibitor (NNRTI)-based treatment regimens has become a problem in HIV-infected children on long-term antiretroviral therapy (ART). Protease inhibitor (PI)-based regimens are therefore often given to children failing N...

Saved in:

書目詳細資料
Main Authors:	N. Wattanutchariya, V. Sirisanthana, P. Oberdorfer
格式:	雜誌
出版:	2018
主題:	Medicine
在線閱讀:	https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84874544986&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/52879
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

Effectiveness and safety of protease inhibitor-based regimens in HIV-infected Thai children failing first-line treatment
由: N. Wattanutchariya, et al.
出版: (2018)

Effectiveness and safety of protease inhibitor-based regimens in HIV-infected Thai children failing first-line treatment
由: Wattanutchariya N., et al.
出版: (2014)

Second-line protease inhibitor-based HAART after failing non-nucleoside reverse transcriptase inhibitorbased regimens in Asian HIV-infected children
由: Torsak Bunupuradah, et al.
出版: (2018)

Second-line protease inhibitor-based HAART after failing non-nucleoside reverse transcriptase inhibitorbased regimens in Asian HIV-infected children
由: Torsak Bunupuradah, et al.
出版: (2018)

Second-line protease inhibitor-based HAART after failing non-nucleoside reverse transcriptase inhibitorbased regimens in Asian HIV-infected children
由: Torsak Bunupuradah, et al.
出版: (2018)

Efficacy and tolerability of a double boosted protease inhibitor (lopinavir + saquinavir/ritonavir) regimen in HIV-infected patients who failed treatment with nonnucleoside reverse transcriptase inhibitors
由: P. Chetchotisakd, et al.
出版: (2018)

Efficacy and tolerability of a double boosted protease inhibitor (lopinavir + saquinavir/ritonavir) regimen in HIV-infected patients who failed treatment with nonnucleoside reverse transcriptase inhibitors
由: P. Chetchotisakd, et al.
出版: (2018)

Treatment failure in HIV-infected children on second-line protease inhibitor-based antiretroviral therapy
由: Rapeepan Suaysod, et al.
出版: (2018)

Treatment failure in HIV-infected children on second-line protease inhibitor-based antiretroviral therapy
由: Rapeepan Suaysod, et al.
出版: (2018)

Efficacy and safety of abacavir/lamivudine plus rilpivirine as a first-line regimen in treatment-naïve HIV-1 infected adults
由: Ho, Sharlene, et al.
出版: (2021)

Efficacy and safety of abacavir/lamivudine plus rilpivirine as a first-line regimen in treatment-naïve HIV-1 infected adults
由: Ho, S., et al.
出版: (2021)

Impact of HIV-1 viral load on genotypic characteristics among patients failing non-nucleoside reverse trancriptase inhibitor-based first-line regimens in Northern Thailand
由: Jutarat Praparattanapan, et al.
出版: (2018)

Impact of HIV-1 viral load on genotypic characteristics among patients failing non-nucleoside reverse trancriptase inhibitor-based first-line regimens in Northern Thailand
由: Praparattanapan J., et al.
出版: (2014)

Impact of HIV-1 viral load on genotypic characteristics among patients failing non-nucleoside reverse trancriptase inhibitor-based first-line regimens in Northern Thailand
由: Praparattanapan J., et al.
出版: (2014)

Patients infected with HIV type 1 subtype CRF01-AE and failing first-line nevirapine- and efavirenz-based regimens demonstrate considerable cross-resistance to etravirine
由: Weerawat Manosuthi, et al.
出版: (2018)

Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails
由: Somnuek Sungkanuparph, et al.
出版: (2018)

Resistance patterns selected by nevirapine vs. efavirenz in HIV-infected patients failing first-line antiretroviral treatment: A Bayesian analysis
由: Nicole Ngo-Giang-Huong, et al.
出版: (2018)

Resistance patterns selected by nevirapine vs. efavirenz in HIV-infected patients failing first-line antiretroviral treatment: A Bayesian analysis
由: Ngo-Giang-Huong N., et al.
出版: (2014)

Factors associated with pre-treatment HIV RNA: Application for the use of abacavir and rilpivirine as the first-line regimen for HIV-infected patients in resource-limited settings
由: Sasisopin Kiertiburanakul, et al.
出版: (2018)

Etravirine and rilpivirine resistance in HIV-1 subtype CRF01-AE-infected adults failing non-nucleoside reverse transcriptase inhibitor-based regimens
由: Torsak Bunupuradah, et al.
出版: (2018)

High rate multiple drug resistances in HIV-infected patients failing nonnucleoside reverse transcriptase inhibitor regimens in Thailand, where subtype A/E is predominant
由: Ploenchan Chetchotisakd, et al.
出版: (2018)

High rate multiple drug resistances in HIV-infected patients failing nonnucleoside reverse transcriptase inhibitor regimens in Thailand, where subtype A/E is predominant
由: Ploenchan Chetchotisakd, et al.
出版: (2018)

Single-boosted protease inhibitor versus double-boosted protease inhibitors for the salvage therapy in HIV-infected patients
由: Weerawat Manosuthi, et al.
出版: (2018)

High virologic response rate after second-line boosted protease inhibitor-based antiretroviral therapy regimens in children from a resource limited setting
由: Thanyawee Puthanakit, et al.
出版: (2018)

High virologic response rate after second-line boosted protease inhibitor-based antiretroviral therapy regimens in children from a resource limited setting
由: Puthanakit T., et al.
出版: (2014)

High virologic response rate after second-line boosted protease inhibitor-based antiretroviral therapy regimens in children from a resource limited setting
由: Thanyawee Puthanakit, et al.
出版: (2018)

Metabolic Disorders in HIV-Infected Adolescents Receiving Protease Inhibitors
由: Jeerunda Santiprabhob, et al.
出版: (2018)

Disclosure of HIV/AIDS diagnosis to HIV-infected children in Thailand
由: Oberdorfer P., et al.
出版: (2014)

Recommended First-Line Antiretroviral Therapy Regimens and Risk of Diabetes Mellitus in HIV-Infected Adults in Resource-Limited Settings
由: Ninutcha Paengsai, et al.
出版: (2020)

Recommended First-Line Antiretroviral Therapy Regimens and Risk of Diabetes Mellitus in HIV-Infected Adults in Resource-Limited Settings
由: Ninutcha Paengsai, et al.
出版: (2020)

Quality of life among HIV-infected children in Thailand.
由: Oberdorfer P., et al.
出版: (2014)

Quality of life among HIV-infected children in Thailand
由: Oberdorfer P., et al.
出版: (2014)

Disclosure of HIV/AIDS diagnosis to HIV-infected children in Thailand
由: Peninnah Oberdorfer, et al.
出版: (2018)

Causes of first hospitalization among 1121 HIV-infected children: comparison of the pre-Pneumocystis jiroveci pneumonia prophylaxis, pre-antiretroviral therapy and antiretroviral therapy periods
由: Sudjaritruk T., et al.
出版: (2014)

Causes of first hospitalization among 1121 HIV-infected children: Comparison of the pre-Pneumocystis jiroveci pneumonia prophylaxis, pre-antiretroviral therapy and antiretroviral therapy periods
由: T. Sudjaritruk, et al.
出版: (2018)

Plasma levels, safety, and 60-week efficacy of a once-daily double-boosted protease inhibitor regimen of atazanavir, saquinavir, and ritonavir
由: Weerawat Manosuthi, et al.
出版: (2018)

Quality of life among HIV-infected children in Thailand
由: Peninnah Oberdorfer, et al.
出版: (2018)

Computational investigations of HIV-1 protease and protease inhibitors interactions
由: Sham, Hoi Fung
出版: (2014)

Risk of first-line antiretroviral therapy failure in HIV-infected Thai children and adolescents
由: Torsak Bunupuradah, et al.
出版: (2018)

Incidence and predictors of severe anemia in Asian HIV-infected children using first-line antiretroviral therapy
由: Torsak Bunupuradah, et al.
出版: (2018)